The present invention comprises methods and compositions for the reduction ofoxalate in humans, and methodsfor the purification and isolation of recombinant oxalate reducing enzymeproteins. The invention provides methods and compositionsfor the delivery of oxalate-reducing enzymes in particle compositions. Thecompositions of the present invention are suitablein methods of treatment or prevention of oxalate-related conditions.